报价延迟最少15分钟:2025/10/23 17:33 EDT
盘后时段
|
||||
|
253.51 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
253.51
|
|
|
| 价值评估 |
|
盈利(现时/预测)
3.78/4.88
|
|
企业价值
10.04B
|
| 资产负债 |
|
每股账面净值
33.18
|
| 现金流量 |
|
现金流量率
0.02
|
| 损益表 |
|
收益
1.19B
|
|
每股收益
25.51
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/10/23 17:33 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases. |
